BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 307007)

  • 1. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS; Abildgaard CF; Meyer D
    N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J; Tran-Thang C; Bachmann F
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1773-5. PubMed ID: 3879003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS; Voss R; Edgington TS
    J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease.
    Holmbeg L; Nilsson IM
    Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Factor VIII related antigen in normal blood platelets and in platelets of patients with von Willebrand's disease.
    Bouma BN; Hordijk-Hos JM; de Graaf S; van Mourik JA; Sixma JJ
    Thromb Diath Haemorrh; 1975 Nov; 34(2):606-7. PubMed ID: 1081754
    [No Abstract]   [Full Text] [Related]  

  • 17. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR; Sultan Y; Coller BS
    N Engl J Med; 1977 May; 296(18):1024-30. PubMed ID: 300468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.